Why the Chicago Cubs should say no to Tarik Skubal
There aren’t too many people who actually believe that the Chicago Cubs will end up bagging prized free agent pitcher Tarik Skubal.
More News: Chicago Cubs: Edward Cabrera’s turnaround is essential to 2027 success
The two-time Cy Young Award-winning starting pitcher is expected to command upwards of $45 million a year over an eight-year contract when he becomes a free agent at the end of this 2026 season. Some estimates put him squarely at the $50 million-per-season mark.
It’s just not in the Cubs’ DNA to pay that much for anybody, but especially not for a pitcher.
Cubs president of baseball operations Jed Hoyer has shied away from laying out big money for big-ticket pitching and has come up short in his efforts to do so when he’s explored the possibility—notably with Dylan Cease last offseason and closer Tanner Scott the offseason before that.
Not in the running for Skubal?

More News: Chicago Cubs linked to Japanese stars ahead of uncertain offseason
MLB Network’s Jon Morosi echoed the skepticism when it comes to Chicago spending big on Skubal in an interview with 104.3 The Score’s Spiegel and Holmes show.
“I think on the pitching aspect of this, you need a little bit more swing-and-miss, you need probably a true No. 1,” Morosi said. “And they’re gonna honestly have to look at it and say, ‘Are we ready to go toe to toe with the New York Mets and maybe the Dodgers in the bidding for Skubal?’ I tend to think they will fall short, but that is the type of person — they are a Skubal away, in my opinion, a Skubal or a true ace away.”
That’s a sobering reality check, but it’s not exactly a surprise that the Cubs wouldn’t win a bidding war with teams like the Dodgers or Mets. In this particular case, though, it’s probably a good thing that they won’t be in the running for Skubal.
Cubs are more than just one ace away

Let’s face it, the Cubs are more than just one starting pitcher away from making a serious postseason run—even if that one pitcher is a Hall of Fame-level ace.
Even pushing the boundaries of optimism, the Cubs probably need at least two or three starters heading into 2027 and a reliable back-of-bullpen reliever. Spending $360-$400 million on one pitcher this offseason would probably close the door on any other high-end (or even mid-level) pitching purchases.
With their entire end-of-season rotation likely hitting free agency and lots of starting pitching uncertainty left behind, the team needs bulk and not just one key asset. There WILL be a good amount of money coming off the books, but using half of it on one player just wouldn’t be smart.
For what the Cubs would spend on signing Skubal, they could get Michael King for the front of the rotation and then could re-sign David Peterson for the back of the rotation, while also possibly having enough to sign someone like Adrian Morejon for a closer role.
At this point in the baseball year, all of this is just wild speculation. But there’s no denying the fact that the Cubs need pitching and that their farm system will not be contributing much to filling any major league pitching staff holes in 2027. Hoyer and company will have to go out and spend, even if they don’t take a stab at landing the biggest fish available.
The post Why the Chicago Cubs should say no to Tarik Skubal appeared first on ChiCitySports.
Source: https://www.chicitysports.com/chicago-cubs-tarik-skubal-free-agent-2027/
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.

